Waitlist Outcomes for Children With Congenital Heart Disease: Lessons Learned From Over 5000 Heart Transplant

Madeleine Townsend1, Tara Karamlou2, Gerard Boyle3

  • 1Department of Pediatrics, Stollery Children's Hospital, University of Alberta, Edmonton, Canada.

Insights

Pediatric heart transplant waitlist survival for children with congenital heart disease (CHD) has improved over time, but outcomes remain worse than for cardiomyopathy patients. Ventricular assist device (VAD) therapy may enhance future waitlist results.

Area of Science:

  • Pediatric Cardiology
  • Transplant Surgery
  • Medical Device Technology

Background:

  • Examining pediatric heart transplant policy changes and ventricular assist device (VAD) approval impacts.
  • Assessing waitlist (WL) outcomes for children with congenital heart disease (CHD).

Purpose of the Study:

  • To evaluate the effect of evolving pediatric heart allocation policies and the Berlin VAD on WL outcomes for pediatric CHD patients.
  • To compare WL outcomes for CHD patients across different time eras and with cardiomyopathy (CMP) patients.

Main Methods:

  • Analysis of the Scientific Registry of Transplant Recipients database (1999-2019).
  • Inclusion of all pediatric patients (<18 years) with CHD and cardiomyopathy (CMP) on the WL.
  • Stratification into four eras: 1999-2008, 2009-2011, 2012-2016, and 2016-2019.

Main Results:

  • Waitlist survival for children with CHD significantly improved from Era 1 to Era 4 (P < .001).
  • Patients listed in Era 4 were less likely to be infants or on mechanical support (ventilation/ECMO) but more likely to be on a VAD compared to earlier eras.
  • Despite improvements, children with CHD in Era 4 had inferior WL survival compared to CMP patients (P < .001).

Conclusions:

  • Children with CHD are increasingly listed with less advanced heart failure, showing improved WL survival over time.
  • Pediatric WL outcomes for CHD patients remain poorer than for CMP patients.
  • Advancements in pediatric medical care and VAD technology hold promise for improving future WL outcomes.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
67
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
545
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
528
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
82
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
90